| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5692567 | European Urology | 2016 | 4 Pages |
Abstract
In this report we found known, as well as previously unreported, genetic mutations in the tumors of patients with high-risk bladder cancer. These mutations, if validated, may serve as actionable targets for new trials.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Thomas Longo, Kathleen F. McGinley, Jennifer A. Freedman, Wiguins Etienne, Yuan Wu, Alexander Sibley, Kouros Owzar, Jeremy Gresham, Christopher Moy, Stephen Szabo, Joel Greshock, Hui Zhou, Yuchen Bai, Brant A. Inman,